Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27672332)

Published in Onco Targets Ther on September 09, 2016

Authors

Sun-Hye Ko1, Myong Ki Baeg2, Woong Jin Bae3, Pumsoo Kim4, Myung-Gyu Choi5

Author Affiliations

1: Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
2: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Department of Internal Medicine, International St Mary's Hospital, Catholic Kwandong University, Incheon, South Korea.
3: Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
4: Department of Internal Medicine, International St Mary's Hospital, Catholic Kwandong University, Incheon, South Korea.
5: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Articles cited by this

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med (2004) 15.10

Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09

Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05

Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene (2006) 4.14

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology (2007) 3.60

Prevention and early detection of prostate cancer. Lancet Oncol (2014) 2.94

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer (2012) 2.61

Cancer incidence after localized therapy for prostate cancer. Cancer (2006) 2.52

Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol (2011) 2.24

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut (2010) 2.16

State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer (2010) 2.08

Is in vivo measurement of size of polyps during colonoscopy accurate? Gastrointest Endosc (1997) 1.93

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett (2005) 1.90

Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. BJU Int (2012) 1.84

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J Natl Cancer Inst (2005) 1.75

Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol (2007) 1.63

Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst (2010) 1.63

BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res (2004) 1.61

Colon cancer: a civilization disorder. Dig Dis (2011) 1.49

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology (2014) 1.48

Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol (2009) 1.34

American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin (2014) 1.29

The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol (2002) 1.16

Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol (2013) 1.14

Biology of prostate-specific antigen. Urology (2003) 1.05

Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes Control (2013) 1.02

Prevalence of multiple malignancies in the Netherlands in 2007. Int J Cancer (2010) 1.01

Role of preoperative colonoscopy in patients with gastric cancer: a case control study of the prevalence of coexisting colorectal neoplasms. Ann Surg Oncol (2013) 0.90

Primary cancers before and after prostate cancer diagnosis. Cancer (2012) 0.89

Precancerous colorectal lesions (Review). Int J Oncol (2013) 0.89

Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010. Cancer Epidemiol (2013) 0.87

Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. Cancer (2014) 0.84

Increased cumulative incidence of prostate malignancies in colorectal cancer patients. Int J Gastrointest Cancer (2003) 0.83

Association of colorectal adenoma with other malignancies in Swedish families. Br J Cancer (2008) 0.83

Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol (2012) 0.82

Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study. Anticancer Res (2000) 0.81

Incidence of second malignancies for prostate cancer. PLoS One (2014) 0.81

Incidence and risk factors for colorectal neoplasia in patients with oral squamous cell carcinoma. Colorectal Dis (2014) 0.79

Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev (2014) 0.79

Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case-control study. Int J Colorectal Dis (2014) 0.78

Men with colorectal cancer are predisposed to prostate cancer. ANZ J Surg (2003) 0.76